logo-loader
viewIntegumen

Full interview: Integumen agrees three new R&D deals with top 20 global cosmetic firms

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott following the announcement they've signed commercial agreements with three companies.

He didn't reveal the identities of the customers, but says they're top-20 cosmetic firms.

Brandon also confirms they're on track to exceed £1mln in revenues by the year-end.

Quick facts: Integumen

Price: 2.6038 GBX

AIM:SKIN
Market: AIM
Market Cap: £28.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen's Gerry Brandon details new £3mln facility for Labskin and...

Integumen's (LON:SKIN) Gerry Brandon speaks to Proactive London's Andrew Scott after announcing they've secured a new £3mln three-year loan facility that requires no loan repayments until next year. He says the initial drawdown of £1.5mln provides them with sufficient working capital for its...

2 weeks, 1 day ago

2 min read